The Journal of Thoracic and Cardiovascular Surgery, Vol 84, 685-688, Copyright © 1982 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
Experimental evaluation of magnesium cardioplegia
A Wakabayashi, T Nishi and JE Guilmette
The effectiveness of magnesium solution in protecting ischemic myocardium
was evaluated in a blood-perfused, isolated rabbit papillary muscle
preparation. Anoxic cardioplegia was induced by either a control solution
containing no magnesium or a test solution containing a magnesium
concentration of 160 mEq/L. The magnesium solution induced a very rapid
cardiac arrest, less than 1 minute, in contrast to more than 10 minutes
with the control solution. Restarting time was not affected by magnesium
cardioplegia. Following 30 minutes of anoxic cardioplegia, the magnesium
group showed significantly (p less than 0.01) better recovery of myocardial
contractility, 91.3% +/- 8.3% (n = 6), than the control group, 77.7% +/-
4.1% (n = 6). These protective effects of magnesium were lost when the
ischemic time was longer than 45 minutes.